Rigel Announces Five Poster Presentations at the Upcoming 64th American Society of Hematology Annual Meeting and Exposition

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the upcoming presentation of five posters highlighting data from the Company's...

Related Keywords

United States ,Florida ,California ,Georgia ,South San Francisco ,Massachusetts ,American ,Cecilf Whitaker Jr ,Vadimv Markovtsov ,David Rosen ,Mehdim Moezi ,Raul Rodriguez ,Davidj Kuter ,Jorgee Cortes ,Vickie Mcdonald ,Hematology Am Soc Hematol Educ Program ,Consultant Haematologist At Barts Health ,Nasdaq ,American Society Of Hematology ,Prnewswire Rigel Pharmaceuticals Inc ,Rigel Pharmaceuticals ,Georgia Cancer Center ,A Network Meta ,American Cancer Society ,Rigel Pharmaceuticals Inc ,Drug Administration ,Professor Of Medicine At Harvard Medical School ,Ernestn Morial Convention Center ,Outcomes Research ,Exchange Commission ,American Society ,Annual Meeting ,New Orleans ,New Drug Application ,Prescription Drug User Fee Act ,Scholar Chair ,Myeloid Leukemias ,Investigational Therapies ,Excluding Transplantation ,Convention Center ,Cancer Specialists ,Non Malignant Conditions ,Clinical Hematology ,Massachusetts General Hospital ,Harvard Medical School ,Excluding Iron ,Comparative Effectiveness ,Refractory Chronic Immune Thrombocytopenia ,Consultant Haematologist ,Barts Health ,Platelet Number ,Practice Guidelines ,Acute Myeloid ,American Cancer ,Revised January ,Acute Myeloid Leukaemia ,Hematology Am Soc Hematol Educ ,Quarterly Report ,Nc ,